価格
始める
米国企業
Can B Corp
Raw
Can B Corp
【NASC】
時価総額
$128.9万
PER
ヘンプ由来カンナビノイド製品の開発・製造・販売、医療機器ライセンス事業の新興企業。オイルやクリーム、ジェルカプセル等のCBD製品を展開。23年12月に購入価格25,000ドルで37,500ドルの転換社債発行、24年3月14日にヘンプ部門資産が競売。米国(ワシントン州製造拠点)中心に展開。
マイリストに追加
マイリストに追加
株価
業績
サマリーテーブルに戻る
十億
百万
千
USD
年次
四半期
Download CSV
2019年
12月31日
2020年
12月31日
2021年
12月31日
2022年
12月31日
2023年
12月31日
Net loss
-4,592,470
-5,716,511
-12,169,395
-14,924,175
-9,737,464
Stock-based compensation
3
2
2
5
1
Common stock in lieu of cash payroll
-
-
-
-
589,216
Depreciation
12,627
16,475
493,656
1
1
Amortization of intangible assets
142,093
658,910
48,689
26,906
12,000
Amortization of original-issue-discounts
-
273,607
2
444,920
1
Bad debt expense
-
270,919
61,393
751,025
2
Impairment of intangible assets
-
-
-
252,462
-
Cancellation of debt
-
-
-
-
-110,000
Change in fair value of warrant liability
-
-
-
-154,010
-201,277
Stock-based interest expense
-
451,680
199,314
73,078
328,932
Stock-based consulting expense
-
-
-
4
1
Accounts receivable
1
1
2
4
-1,029,499
Inventory
209,893
-931,523
2
-529,385
-580,011
Prepaid expenses
4,760
10,797
-8,476
14,327
-16,887
Operating lease right-of-use asset
-299
-525
20,667
26,764
-5,847
Accounts payable
153,408
-72,827
2
2
-954,904
Accrued expenses
-
-
457,033
-475,828
-
Net cash used in operating activities
-2,413,420
-1,947,091
-7,322,732
-3,947,424
-1,304,495
Purchase of property and equipment
1
50,219
538,763
-
15,000
Deposits paid
-
-
144,500
-
69,631
Net cash used in investing activities
-1,660,282
-25,249
-860,793
-
-84,631
Net proceeds received from notes and loans payable
35,000
5
2
3
2
Proceeds from sale of common stock
3
300,000
7
500,000
-
Repayments of notes and loans payable
19,205
1
224,000
377,500
939,062
Deferred financing costs
-
518,120
-
77,706
178,000
Amounts received from related parties, net
-
-
-
-
62,000
Net cash provided by financing activities
3
2
8
4
1
Decrease in cash and cash equivalents
-761,207
411,258
-8,797
-375,807
-39,188
Income taxes paid
2,084
3,304
1,075
1,075
-
Interest paid
8,793
206,328
4,000
83,147
-
Issuance of common stock in lieu of repayment of notes payable
-
-
537,748
-
1
Issuance of common stock in asset acquisitions
-
929,734
3
2
175,500
Issuance of common stock for property and equipment
-
-
3
-
46,875
Debt discount associated with warrant liability
-
-
-
-
273,529
Issuance of common stock resulting from the exercise of warrants
-
-
-
8,641
-
Issuance of common stock warrants and commitment shares in connection with convertible promissory note
-
-
515,276
-
937,787